UCP2 and Parkinson disease: Indeed, mice with enhanced Ucp2-expression in the hippocampus, substantia nigra, or striatum, resisted to neurodegeneration in models of epilepsy [7], Parkinson's disease [13], [18], [19], and global ischemia [20].